Cellular uptake and intracellular trafficking of antisense and siRNA oligonucleotides

Bioconjugate Chemistry

Volumn 23, Issue 2, 2012, Pages 147-157

  Juliano, Rudolph L ^a   Ming, Xin ^a   Nakagawa, Osamu ^a  

^a University of North Carolina   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MACHINERY;

ANIMAL MODEL; ANTISENSE; CELLULAR MODELING; CELLULAR UPTAKE; CLINICAL STUDY; FREE MOLECULES; INTRACELLULAR TRAFFICKING; SUBCELLULAR TRAFFICKING; TARGETING LIGANDS; THERAPEUTIC AGENTS;

OLIGONUCLEOTIDES;

AMPHIPHYSIN; ANTISENSE OLIGONUCLEOTIDE; ASIALOGLYCOPROTEIN RECEPTOR; AUXILIN; CAVEOLIN; CELL PENETRATING PEPTIDE; CHAPERONE; CLATHRIN; DYNAMIN; G PROTEIN COUPLED RECEPTOR; GENE THERAPY AGENT; HEAT SHOCK COGNATE PROTEIN 70; HYBRID PROTEIN; LIPOPLEX; LOCKED NUCLEIC ACID; MACROGOL; MORPHOLINE; N ACETYLGALACTOSAMINE; NANOCARRIER; PEPTIDE NUCLEIC ACID; RAB PROTEIN; SMALL INTERFERING RNA; SNARE PROTEIN; SOLID LIPID NANOPARTICLE; SPLICE SHIFTING OLIGONUCLEOTIDE; TOLL LIKE RECEPTOR; TRANSFERRIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANTISENSE THERAPY; CAVEOLA; CELL MIGRATION; DRUG CONJUGATION; DRUG UPTAKE; DUCHENNE MUSCULAR DYSTROPHY; ENDOCYTOSIS; ENTOSIS; GENE DELIVERY SYSTEM; GENE THERAPY; GENETIC TRANSFECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERNALIZATION; INTRACELLULAR SIGNALING; INTRACELLULAR TRANSPORT; LIVER CARCINOMA; NONHUMAN; PHAGOCYTOSIS; PINOCYTOSIS; REVIEW; RNA SPLICING; VIRUS ENCEPHALITIS; VIRUS ENTRY;

ANIMALIA;

EID: 84856834692     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/bc200377d     Document Type: Review

References (138)

1. Zamecnik, P. C. and Stephenson, M. L. (1978) Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide Proc. Natl. Acad. Sci. U. S. A. 75, 280-4 (Pubitemid 8290783)
2. Mello, C. C. and Conte, D., Jr. (2004) Revealing the world of RNA interference Nature 431, 338-42 (Pubitemid 39265673)
3. Elbashir, S. M., Harborth, J., Lendeckel, W., Yalcin, A., Weber, K., and Tuschl, T. (2001) Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells Nature 411, 494-8 (Pubitemid 32494397)
4. Moazed, D. (2009) Small RNAs in transcriptional gene silencing and genome defence Nature 457, 413-20
5. Bennett, C. F. and Swayze, E. E. (2010) RNA targeting therapeutics: molecular mechanisms of antisense oligonucleotides as a therapeutic platform Annu. Rev. Pharmacol. Toxicol. 50, 259-93
6. Castanotto, D. and Rossi, J. J. (2009) The promises and pitfalls of RNA-interference-based therapeutics Nature 457, 426-33
7. Krutzfeldt, J., Rajewsky, N., Braich, R., Rajeev, K. G., Tuschl, T., Manoharan, M., and Stoffel, M. (2005) Silencing of microRNAs in vivo with 'antagomirs' Nature 438, 685-9
8. Sazani, P. and Kole, R. (2003) Therapeutic potential of antisense oligonucleotides as modulators of alternative splicing J. Clin. Invest. 112, 481-6 (Pubitemid 38056330)
9. Soldati, C., Bithell, A., Conforti, P., Cattaneo, E., and Buckley, N. J. (2011) Rescue of gene expression by modified REST decoy oligonucleotides in a cellular model of Huntington's disease J. Neurochem. 116, 415-25
10. Vollmer, J. and Krieg, A. M. (2009) Immunotherapeutic applications of CpG oligodeoxynucleotide TLR9 agonists Adv. Drug Delivery Rev. 61, 195-204
11. Chin, J. Y. and Glazer, P. M. (2009) Repair of DNA lesions associated with triplex-forming oligonucleotides Mol. Carcinog. 48, 389-99
12. Deleavey, G. F., Watts, J. K., and Damha, M. J. (2009) Chemical modification of siRNA. Current Protocols in Nucleic Acid Chemistry, Chapter 16, Unit 16 3.
13. Corey, D. R. (2007) RNA learns from antisense Nat. Chem. Biol. 3, 8-11 (Pubitemid 46005687)
14. Kurreck, J. (2009) RNA interference: from basic research to therapeutic applications Angew. Chem. 48, 1378-98
15. Vaishnaw, A. K., Gollob, J., Gamba-Vitalo, C., Hutabarat, R., Sah, D., Meyers, R., de Fougerolles, T., and Maraganore, J. (2010) A status report on RNAi therapeutics Silence 1, 14
16. Whitehead, K. A., Langer, R., and Anderson, D. G. (2009) Knocking down barriers: advances in siRNA delivery Nat. Rev. Drug Discovery 8, 129-38
17. Juliano, R., Bauman, J., Kang, H., and Ming, X. (2009) Biological barriers to therapy with antisense and siRNA oligonucleotides Mol. Pharm. 6, 686-95
18. Mayor, S. and Pagano, R. E. (2007) Pathways of clathrin-independent endocytosis Nat. Rev. Mol. Cell Biol. 8, 603-12 (Pubitemid 47106613)
19. Kirkham, M. and Parton, R. G. (2005) Clathrin-independent endocytosis: new insights into caveolae and non-caveolar lipid raft carriers Biochim. Biophys. Acta 1746, 349-63
20. Doherty, G. J. and McMahon, H. T. (2009) Mechanisms of endocytosis Annu. Rev. Biochem. 78, 857-902
21. Mettlen, M., Pucadyil, T., Ramachandran, R., and Schmid, S. L. (2009) Dissecting dynamin's role in clathrin-mediated endocytosis Biochem. Soc. Trans. 37, 1022-6
22. Wolfe, B. L. and Trejo, J. (2007) Clathrin-dependent mechanisms of G protein-coupled receptor endocytosis Traffic 8, 462-70 (Pubitemid 46638559)
23. Lajoie, P. and Nabi, I. R. (2010) Lipid rafts, caveolae, and their endocytosis Int. Rev. Cell Mol. Biol. 282, 135-63
24. Sorkin, A. and von Zastrow, M. (2009) Endocytosis and signalling: intertwining molecular networks Nat. Rev. Mol. Cell Biol. 10, 609-22
25. Lingwood, D. and Simons, K. (2010) Lipid rafts as a membrane-organizing principle Science 327, 46-50
26. Chidlow, J. H., Jr. and Sessa, W. C. (2010) Caveolae, caveolins, and cavins: complex control of cellular signalling and inflammation Cardiovasc. Res. 86, 219-25
27. Glebov, O. O., Bright, N. A., and Nichols, B. J. (2006) Flotillin-1 defines a clathrin-independent endocytic pathway in mammalian cells Nat. Cell Biol. 8, 46-54 (Pubitemid 43064796)
28. Howes, M. T., Mayor, S., and Parton, R. G. (2010) Molecules, mechanisms, and cellular roles of clathrin-independent endocytosis Curr. Opin. Cell Biol. 22, 519-27
29. Kerr, M. C. and Teasdale, R. D. (2009) Defining macropinocytosis Traffic 10, 364-71
30. Kunz, S. (2009) Receptor binding and cell entry of Old World arenaviruses reveal novel aspects of virus-host interaction Virology 387, 245-9
31. Alam, M. R., Ming, X., Dixit, V., Fisher, M., Chen, X., and Juliano, R. L. (2010) The biological effect of an antisense oligonucleotide depends on its route of endocytosis and trafficking Oligonucleotides 20, 103-9
32. Angers, C. G. and Merz, A. J. (2011) New links between vesicle coats and Rab-mediated vesicle targeting Semin. Cell Dev. Biol. 22, 18-26
33. Johannes, L. and Popoff, V. (2008) Tracing the retrograde route in protein trafficking Cell 135, 1175-87
34. Rehman, Z. U., Hoekstra, D., and Zuhorn, I. S. (2011) Protein kinase A inhibition modulates the intracellular routing of gene delivery vehicles in HeLa cells, leading to productive transfection. J. Controlled Release DOI: 10.1016/j.jconrel.2011.07.015.
35. Stenmark, H. (2009) Rab GTPases as coordinators of vesicle traffic Nat. Rev. Mol. Cell Biol. 10, 513-25
36. Hutagalung, A. H. and Novick, P. J. (2011) Role of Rab GTPases in membrane traffic and cell physiology Physiol. Rev. 91, 119-49
37. Bonifacino, J. S. and Hurley, J. H. (2008) Retromer Curr. Opin. Cell Biol. 20, 427-36
38. Brocker, C., Engelbrecht-Vandre, S., and Ungermann, C. (2010) Multisubunit tethering complexes and their role in membrane fusion Curr. Biol. 20, R943-52
39. Malsam, J., Kreye, S., and Sollner, T. H. (2008) Membrane fusion: SNAREs and regulation Cell. Mol. Life Sci. 65, 2814-32
40. Blumenthal, R., Clague, M. J., Durell, S. R., and Epand, R. M. (2003) Membrane fusion Chem. Rev. 103, 53-69
41. Wickner, W. and Schekman, R. (2008) Membrane fusion Nat. Struct. Mol. Biol. 15, 658-64 (Pubitemid 351932008)
42. Weinreb, G. and Lentz, B. R. (2007) Analysis of membrane fusion as a two-state sequential process: evaluation of the stalk model Biophys. J. 92, 4012-29 (Pubitemid 46910587)
43. Allen, T. M., Hong, K., and Papahadjopoulos, D. (1990) Membrane contact, fusion, and hexagonal (HII) transitions in phosphatidylethanolamine liposomes Biochemistry 29, 2976-85 (Pubitemid 20119293)
44. Ortiz, A., Killian, J. A., Verkleij, A. J., and Wilschut, J. (1999) Membrane fusion and the lamellar-to-inverted-hexagonal phase transition in cardiolipin vesicle systems induced by divalent cations Biophys. J. 77, 2003-14 (Pubitemid 29463161)
45. Martens, S. and McMahon, H. T. (2008) Mechanisms of membrane fusion: disparate players and common principles Nat. Rev. Mol. Cell Biol. 9, 543-56 (Pubitemid 351881838)
46. Frolov, V. A., Dunina-Barkovskaya, A. Y., Samsonov, A. V., and Zimmerberg, J. (2003) Membrane permeability changes at early stages of influenza hemagglutinin-mediated fusion Biophys. J. 85, 1725-33 (Pubitemid 37052255)
47. Lorenz, P., Misteli, T., Baker, B. F., Bennett, C. F., and Spector, D. L. (2000) Nucleocytoplasmic shuttling: a novel in vivo property of antisense phosphorothioate oligodeoxynucleotides Nucleic Acids Res. 28, 582-92 (Pubitemid 30057999)
48. Hartig, R., Shoeman, R. L., Janetzko, A., Grub, S., and Traub, P. (1998) Active nuclear import of single-stranded oligonucleotides and their complexes with non-karyophilic macromolecules Biol. Cell 90, 407-26 (Pubitemid 29412679)
49. Juliano, R. L., Alahari, S., Yoo, H., Kole, R., and Cho, M. (1999) Antisense pharmacodynamics: critical issues in the transport and delivery of antisense oligonucleotides Pharm. Res. 16, 494-502 (Pubitemid 29191292)
50. Geary, R. S. (2009) Antisense oligonucleotide pharmacokinetics and metabolism Expert Opin. Drug Metab. Toxicol. 5, 381-91
51. Butler, M., Stecker, K., and Bennett, C. F. (1997) Cellular distribution of phosphorothioate oligodeoxynucleotides in normal rodent tissues Lab. Invest. 77, 379-88 (Pubitemid 27465599)
52. Molitoris, B. A., Dagher, P. C., Sandoval, R. M., Campos, S. B., Ashush, H., Fridman, E., Brafman, A., Faerman, A., Atkinson, S. J., Thompson, J. D., Kalinski, H., Skaliter, R., Erlich, S., and Feinstein, E. (2009) siRNA targeted to p53 attenuates ischemic and cisplatin-induced acute kidney injury J. Am. Soc. Nephrol. 20, 1754-64
53. Koller, E., Vincent, T. M., Chappell, A., De, S., Manoharan, M., and Bennett, C. F. (2011) Mechanisms of single-stranded phosphorothioate modified antisense oligonucleotide accumulation in hepatocytes Nucleic Acids Res. 39, 4795-807
54. Stein, C. A., Hansen, J. B., Lai, J., Wu, S., Voskresenskiy, A., Hog, A., Worm, J., Hedtjarn, M., Souleimanian, N., Miller, P., Soifer, H. S., Castanotto, D., Benimetskaya, L., Orum, H., and Koch, T. (2010) Efficient gene silencing by delivery of locked nucleic acid antisense oligonucleotides, unassisted by transfection reagents Nucleic Acids Res. 38, e3
55. Zhang, Y., Qu, Z., Kim, S., Shi, V., Liao, B., Kraft, P., Bandaru, R., Wu, Y., Greenberger, L. M., and Horak, I. D. (2011) Down-modulation of cancer targets using locked nucleic acid (LNA)-based antisense oligonucleotides without transfection Gene Ther. 18, 326-33
56. Benimetskaya, L., Loike, J. D., Khaled, Z., Loike, G., Silverstein, S. C., Cao, L., el Khoury, J., Cai, T. Q., and Stein, C. A. (1997) Mac-1 (CD11b/CD18) is an oligodeoxynucleotide-binding protein Nat. Med. 3, 414-20 (Pubitemid 27145683)
57. Butler, M., Crooke, R. M., Graham, M. J., Lemonidis, K. M., Lougheed, M., Murray, S. F., Witchell, D., Steinbrecher, U., and Bennett, C. F. (2000) Phosphorothioate oligodeoxynucleotides distribute similarly in class A scavenger receptor knockout and wild-type mice J. Pharmacol. Exp. Ther. 292, 489-96 (Pubitemid 30067410)
58. Hanss, B., Leal-Pinto, E., Bruggeman, L. A., Copeland, T. D., and Klotman, P. E. (1998) Identification and characterization of a cell membrane nucleic acid channel Proc. Natl. Acad. Sci. U. S. A. 95, 1921-6 (Pubitemid 28103495)
59. Hanss, B., Leal-Pinto, E., Teixeira, A., Christian, R. E., Shabanowitz, J., Hunt, D. F., and Klotman, P. E. (2002) Cytosolic malate dehydrogenase confers selectivity of the nucleic acid-conducting channel Proc. Natl. Acad. Sci. U. S. A. 99, 1707-12 (Pubitemid 34136557)
60. Winston, W. M., Sutherlin, M., Wright, A. J., Feinberg, E. H., and Hunter, C. P. (2007) Caenorhabditis elegans SID-2 is required for environmental RNA interference Proc. Natl. Acad. Sci. U. S. A. 104, 10565-70 (Pubitemid 47185705)
61. Duxbury, M. S., Ashley, S. W., and Whang, E. E. (2005) RNA interference: a mammalian SID-1 homologue enhances siRNA uptake and gene silencing efficacy in human cells Biochem. Biophys. Res. Commun. 331, 459-63 (Pubitemid 40602659)
62. Tsang, S. Y., Moore, J. C., Huizen, R. V., Chan, C. W., and Li, R. A. (2007) Ectopic expression of systemic RNA interference defective protein in embryonic stem cells Biochem. Biophys. Res. Commun. 357, 480-6 (Pubitemid 46603156)
63. Wolfrum, C., Shi, S., Jayaprakash, K. N., Jayaraman, M., Wang, G., Pandey, R. K., Rajeev, K. G., Nakayama, T., Charrise, K., Ndungo, E. M., Zimmermann, T., Koteliansky, V., Manoharan, M., and Stoffel, M. (2007) Mechanisms and optimization of in vivo delivery of lipophilic siRNAs Nat. Biotechnol. 25, 1149-57 (Pubitemid 47538115)
64. Overhoff, M. and Sczakiel, G. (2005) Phosphorothioate-stimulated uptake of short interfering RNA by human cells EMBO Rep. 6, 1176-81 (Pubitemid 41741702)
65. Robbins, M., Judge, A., and MacLachlan, I. (2009) siRNA and innate immunity Oligonucleotides 19, 89-102
66. Kawai, T. and Akira, S. (2011) Toll-like receptors and their crosstalk with other innate receptors in infection and immunity Immunity 34, 637-50
67. Kortylewski, M., Swiderski, P., Herrmann, A., Wang, L., Kowolik, C., Kujawski, M., Lee, H., Scuto, A., Liu, Y., Yang, C., Deng, J., Soifer, H. S., Raubitschek, A., Forman, S., Rossi, J. J., Pardoll, D. M., Jove, R., and Yu, H. (2009) In vivo delivery of siRNA to immune cells by conjugation to a TLR9 agonist enhances antitumor immune responses Nat. Biotechnol. 27, 925-32
68. Juliano, R. L., Alam, R., Dixit, V., and Kang, H. M. (2009) Cell-targeting and cell-penetrating peptides for delivery of therapeutic and imaging agents Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 1, 324-35
69. Johnson, R. M., Harrison, S. D., and Maclean, D. (2011) Therapeutic applications of cell-penetrating peptides Methods Mol. Biol. 683, 535-51
70. Lindgren, M. and Langel, U. (2011) Classes and prediction of cell-penetrating peptides Methods Mol. Biol. 683, 3-19
71. Ter-Avetisyan, G., Tunnemann, G., Nowak, D., Nitschke, M., Herrmann, A., Drab, M., and Cardoso, M. C. (2009) Cell entry of arginine-rich peptides is independent of endocytosis J. Biol. Chem. 284, 3370-8
72. Saalik, P., Niinep, A., Pae, J., Hansen, M., Lubenets, D., Langel, U., and Pooga, M. (2011) Penetration without cells: Membrane translocation of cell-penetrating peptides in the model giant plasma membrane vesicles J. Controlled Release 153, 117-25
73. Richard, J. P., Melikov, K., Brooks, H., Prevot, P., Lebleu, B., and Chernomordik, L. V. (2005) Cellular uptake of unconjugated TAT peptide involves clathrin-dependent endocytosis and heparan sulfate receptors J. Biol. Chem. 280, 15300-6 (Pubitemid 40562886)
74. Wadia, J. S., Stan, R. V., and Dowdy, S. F. (2004) Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis Nat. Med. 10, 310-5 (Pubitemid 38667624)
75. Fittipaldi, A., Ferrari, A., Zoppe, M., Arcangeli, C., Pellegrini, V., Beltram, F., and Giacca, M. (2003) Cell membrane lipid rafts mediate caveolar endocytosis of HIV-1 Tat fusion proteins J. Biol. Chem. 278, 34141-9 (Pubitemid 37553255)
76. Tunnemann, G., Martin, R. M., Haupt, S., Patsch, C., Edenhofer, F., and Cardoso, M. C. (2006) Cargo-dependent mode of uptake and bioavailability of TAT-containing proteins and peptides in living cells FASEB J. 20, 1775-84 (Pubitemid 44933791)
77. El-Andaloussi, S., Jarver, P., Johansson, H. J., and Langel, U. (2007) Cargo-dependent cytotoxicity and delivery efficacy of cell-penetrating peptides: a comparative study Biochem. J. 407, 285-92 (Pubitemid 47556993)
78. Lebleu, B., Moulton, H. M., Abes, R., Ivanova, G. D., Abes, S., Stein, D. A., Iversen, P. L., Arzumanov, A. A., and Gait, M. J. (2008) Cell penetrating peptide conjugates of steric block oligonucleotides Adv. Drug Delivery Rev. 60, 517-29 (Pubitemid 351217082)
79. Juliano, R., Alam, M. R., Dixit, V., and Kang, H. (2008) Mechanisms and strategies for effective delivery of antisense and siRNA oligonucleotides Nucleic Acids Res. 36, 4158-71 (Pubitemid 351984831)
80. Ivanova, G. D., Arzumanov, A., Abes, R., Yin, H., Wood, M. J., Lebleu, B., and Gait, M. J. (2008) Improved cell-penetrating peptide-PNA conjugates for splicing redirection in HeLa cells and exon skipping in mdx mouse muscle Nucleic Acids Res. 36, 6418-28
81. Abes, R., Moulton, H. M., Clair, P., Yang, S. T., Abes, S., Melikov, K., Prevot, P., Youngblood, D. S., Iversen, P. L., Chernomordik, L. V., and Lebleu, B. (2008) Delivery of steric block morpholino oligomers by (R-X-R)4 peptides: structure-activity studies Nucleic Acids Res. 36, 6343-54
82. Yin, H., Saleh, A. F., Betts, C., Camelliti, P., Seow, Y., Ashraf, S., Arzumanov, A., Hammond, S., Merritt, T., Gait, M. J., and Wood, M. J. (2011) Pip5 transduction peptides direct high efficiency oligonucleotide-mediated dystrophin exon skipping in heart and phenotypic correction in mdx mice Mol. Ther. 19, 1295-303
83. Goyenvalle, A., Babbs, A., Powell, D., Kole, R., Fletcher, S., Wilton, S. D., and Davies, K. E. (2010) Prevention of dystrophic pathology in severely affected dystrophin/utrophin-deficient mice by morpholino-oligomer-mediated exon-skipping Mol. Ther. 18, 198-205
84. Koppelhus, U., Shiraishi, T., Zachar, V., Pankratova, S., and Nielsen, P. E. (2008) Improved cellular activity of antisense peptide nucleic acids by conjugation to a cationic peptide-lipid (CatLip) domain Bioconjugate Chem. 19, 1526-34
85. Deshayes, S., Morris, M., Heitz, F., and Divita, G. (2008) Delivery of proteins and nucleic acids using a non-covalent peptide-based strategy Adv. Drug Delivery Rev. 60, 537-47 (Pubitemid 351222678)
86. Endoh, T. and Ohtsuki, T. (2009) Cellular siRNA delivery using cell-penetrating peptides modified for endosomal escape Adv. Drug Delivery Rev. 61, 704-9
87. Crombez, L., Morris, M. C., Dufort, S., Aldrian-Herrada, G., Nguyen, Q., Mc Master, G., Coll, J. L., Heitz, F., and Divita, G. (2009) Targeting cyclin B1 through peptide-based delivery of siRNA prevents tumour growth Nucleic Acids Res. 37, 4559-69
88. Lundberg, P., El-Andaloussi, S., Sutlu, T., Johansson, H., and Langel, U. (2007) Delivery of short interfering RNA using endosomolytic cell-penetrating peptides FASEB J. 21, 2664-71 (Pubitemid 47372734)
89. Ezzat, K., El Andaloussi, S., Zaghloul, E. M., Lehto, T., Lindberg, S., Moreno, P. M., Viola, J. R., Magdy, T., Abdo, R., Guterstam, P., Sillard, R., Hammond, S. M., Wood, M. J., Arzumanov, A. A., Gait, M. J., Smith, C. I., Hallbrink, M., and Langel, U. (2011) PepFect 14, a novel cell-penetrating peptide for oligonucleotide delivery in solution and as solid formulation Nucleic Acids Res. 39, 5284-98
90. Andaloussi, S. E., Lehto, T., Mager, I., Rosenthal-Aizman, K., Oprea, I. I., Simonson, O. E., Sork, H., Ezzat, K., Copolovici, D. M., Kurrikoff, K., Viola, J. R., Zaghloul, E. M., Sillard, R., Johansson, H. J., Said Hassane, F., Guterstam, P., Suhorutsenko, J., Moreno, P. M., Oskolkov, N., Halldin, J., Tedebark, U., Metspalu, A., Lebleu, B., Lehtio, J., Smith, C. I., and Langel, U. (2011) Design of a peptide-based vector, PepFect6, for efficient delivery of siRNA in cell culture and systemically in vivo Nucleic Acids Res. 39, 3972-87
91. Crombez, L., Aldrian-Herrada, G., Konate, K., Nguyen, Q. N., McMaster, G. K., Brasseur, R., Heitz, F., and Divita, G. (2009) A new potent secondary amphipathic cell-penetrating peptide for siRNA delivery into mammalian cells Mol. Ther. 17, 95-103
92. Said Hassane, F., Abes, R., El Andaloussi, S., Lehto, T., Sillard, R., Langel, U., and Lebleu, B. (2011) Insights into the cellular trafficking of splice redirecting oligonucleotides complexed with chemically modified cell-penetrating peptides J. Controlled Release 153, 163-72
93. Marlin, F., Simon, P., Saison-Behmoaras, T., and Giovannangeli, C. (2010) Delivery of oligonucleotides and analogues: the oligonucleotide conjugate-based approach ChemBioChem 11, 1493-500
94. Corey, D. R. (2007) Chemical modification: the key to clinical application of RNA interference? J. Clin. Invest. 117, 3615-22 (Pubitemid 350224067)
95. Singh, Y., Murat, P., and Defrancq, E. (2010) Recent developments in oligonucleotide conjugation Chem. Soc. Rev. 39, 2054-70
96. Watts, J. K., Deleavey, G. F., and Damha, M. J. (2008) Chemically modified siRNA: tools and applications Drug Discovery Today 13, 842-55
97. Uno, Y., Piao, W., Miyata, K., Nishina, K., Mizusawa, H., and Yokota, T. (2011) High-density lipoprotein facilitates in vivo delivery of alpha-tocopherol-conjugated short-interfering RNA to the brain Hum. Gene Ther. 22, 711-9
98. Li, S., Deshmukh, H. M., and Huang, L. (1998) Folate-mediated targeting of antisense oligodeoxynucleotides to ovarian cancer cells Pharm. Res. 15, 1540-5 (Pubitemid 28465739)
99. Biessen, E. A., Sliedregt-Bol, K., PA, T. H., Prince, P., Van der Bilt, E., Valentijn, A. R., Meeuwenoord, N. J., Princen, H., Bijsterbosch, M. K., Van der Marel, G. A., Van Boom, J. H., and Van Berkel, T. J. (2002) Design of a targeted peptide nucleic acid prodrug to inhibit hepatic human microsomal triglyceride transfer protein expression in hepatocytes Bioconjugate Chem. 13, 295-302 (Pubitemid 34267941)
100. Cesarone, G., Edupuganti, O. P., Chen, C. P., and Wickstrom, E. (2007) Insulin receptor substrate 1 knockdown in human MCF7 ER+ breast cancer cells by nuclease-resistant IRS1 siRNA conjugated to a disulfide-bridged D-peptide analogue of insulin-like growth factor 1 Bioconjugate Chem. 18, 1831-40 (Pubitemid 350219981)
101. Alam, M. R., Dixit, V., Kang, H., Li, Z. B., Chen, X., Trejo, J., Fisher, M., and Juliano, R. L. (2008) Intracellular delivery of an anionic antisense oligonucleotide via receptor-mediated endocytosis Nucleic Acids Res. 36, 2764-76 (Pubitemid 351659588)
102. Ming, X., Alam, M. R., Fisher, M., Yan, Y., Chen, X., and Juliano, R. L. (2010) Intracellular delivery of an antisense oligonucleotide via endocytosis of a G protein-coupled receptor Nucleic Acids Res. 38, 6567-76
103. Nakagawa, O., Ming, X., Huang, L., and Juliano, R. L. (2010) Targeted intracellular delivery of antisense oligonucleotides via conjugation with small-molecule ligands J. Am. Chem. Soc. 132, 8848-9
104. Thiel, K. W. and Giangrande, P. H. (2009) Therapeutic applications of DNA and RNA aptamers Oligonucleotides 19, 209-22
105. McNamara, J. O., 2nd, Andrechek, E. R., Wang, Y., Viles, K. D., Rempel, R. E., Gilboa, E., Sullenger, B. A., and Giangrande, P. H. (2006) Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras Nat. Biotechnol. 24, 1005-15 (Pubitemid 44215395)
106. Dassie, J. P., Liu, X. Y., Thomas, G. S., Whitaker, R. M., Thiel, K. W., Stockdale, K. R., Meyerholz, D. K., McCaffrey, A. P., McNamara, J. O., 2nd, and Giangrande, P. H. (2009) Systemic administration of optimized aptamer-siRNA chimeras promotes regression of PSMA-expressing tumors Nat. Biotechnol. 27, 839-49
107. Pastor, F., Kolonias, D., Giangrande, P. H., and Gilboa, E. (2010) Induction of tumour immunity by targeted inhibition of nonsense-mediated mRNA decay Nature 465, 227-30
108. Wheeler, L. A., Trifonova, R., Vrbanac, V., Basar, E., McKernan, S., Xu, Z., Seung, E., Deruaz, M., Dudek, T., Einarsson, J. I., Yang, L., Allen, T. M., Luster, A. D., Tager, A. M., Dykxhoorn, D. M., and Lieberman, J. (2011) Inhibition of HIV transmission in human cervicovaginal explants and humanized mice using CD4 aptamer-siRNA chimeras J. Clin. Invest. 121, 2401-12
109. Ming, X. (2011) Cellular delivery of siRNA and antisense oligonucleotides via receptor-mediated endocytosis Expert Opin. Drug Delivery 8, 435-49
110. Geary, R. S., Wancewicz, E., Matson, J., Pearce, M., Siwkowski, A., Swayze, E., and Bennett, F. (2009) Effect of dose and plasma concentration on liver uptake and pharmacologic activity of a 2′-methoxyethyl modified chimeric antisense oligonucleotide targeting PTEN Biochem. Pharmacol. 78, 284-91
111. Caswell, P. T., Vadrevu, S., and Norman, J. C. (2009) Integrins: masters and slaves of endocytic transport Nat. Rev. Mol. Cell Biol. 10, 843-53
112. Hanyaloglu, A. C. and von Zastrow, M. (2008) Regulation of GPCRs by endocytic membrane trafficking and its potential implications Annu. Rev. Pharmacol. Toxicol. 48, 537-68 (Pubitemid 351738163)
113. Sorkin, A. and Goh, L. K. (2009) Endocytosis and intracellular trafficking of ErbBs Exp. Cell Res. 315, 683-96
114. Akhtar, S. and Benter, I. F. (2007) Nonviral delivery of synthetic siRNAs in vivo J. Clin. Invest. 117, 3623-32 (Pubitemid 350224068)
115. Tamura, A. and Nagasaki, Y. (2010) Smart siRNA delivery systems based on polymeric nanoassemblies and nanoparticles Nanomedicine (Lond.) 5, 1089-102
116. Love, K. T., Mahon, K. P., Levins, C. G., Whitehead, K. A., Querbes, W., Dorkin, J. R., Qin, J., Cantley, W., Qin, L. L., Racie, T., Frank-Kamenetsky, M., Yip, K. N., Alvarez, R., Sah, D. W., de Fougerolles, A., Fitzgerald, K., Koteliansky, V., Akinc, A., Langer, R., and Anderson, D. G. (2010) Lipid-like materials for low-dose, in vivo gene silencing Proc. Natl. Acad. Sci. U. S. A. 107, 1864-9
117. Kabanov, A. V. and Vinogradov, S. V. (2009) Nanogels as pharmaceutical carriers: finite networks of infinite capabilities Angew. Chem., Int. Ed. Engl. 48, 5418-29
118. Petros, R. A. and DeSimone, J. M. (2010) Strategies in the design of nanoparticles for therapeutic applications Nat. Rev. Drug Discovery 9, 615-27
119. Tseng, Y. C., Mozumdar, S., and Huang, L. (2009) Lipid-based systemic delivery of siRNA Adv. Drug Delivery Rev. 61, 721-31
120. Lv, H., Zhang, S., Wang, B., Cui, S., and Yan, J. (2006) Toxicity of cationic lipids and cationic polymers in gene delivery J. Controlled Release 114, 100-9 (Pubitemid 44128621)
121. Akhtar, S. (2010) Cationic nanosystems for the delivery of small interfering ribonucleic acid therapeutics: a focus on toxicogenomics Expert Opin. Drug Metab. Toxicol. 6, 1347-62
122. Lu, J. J., Langer, R., and Chen, J. (2009) A novel mechanism is involved in cationic lipid-mediated functional siRNA delivery Mol. Pharm. 6, 763-71
123. Kaneda, M. M., Sasaki, Y., Lanza, G. M., Milbrandt, J., and Wickline, S. A. (2010) Mechanisms of nucleotide trafficking during siRNA delivery to endothelial cells using perfluorocarbon nanoemulsions Biomaterials 31, 3079-86
124. Ming, X., Sato, K., and Juliano, R. L. (2011) Unconventional internalization mechanisms underlying functional delivery of antisense oligonucleotides via cationic lipoplexes and polyplexes J. Controlled Release 153, 83-92
125. Pirollo, K. F. and Chang, E. H. (2008) Targeted delivery of small interfering RNA: approaching effective cancer therapies Cancer Res. 68, 1247-50 (Pubitemid 351346828)
126. Kumar, P., Wu, H., McBride, J. L., Jung, K. E., Kim, M. H., Davidson, B. L., Lee, S. K., Shankar, P., and Manjunath, N. (2007) Transvascular delivery of small interfering RNA to the central nervous system Nature 448, 39-43 (Pubitemid 47037001)
127. Kumar, P., Ban, H. S., Kim, S. S., Wu, H., Pearson, T., Greiner, D. L., Laouar, A., Yao, J., Haridas, V., Habiro, K., Yang, Y. G., Jeong, J. H., Lee, K. Y., Kim, Y. H., Kim, S. W., Peipp, M., Fey, G. H., Manjunath, N., Shultz, L. D., Lee, S. K., and Shankar, P. (2008) T cell-specific siRNA delivery suppresses HIV-1 infection in humanized mice Cell 134, 577-86
128. Kim, S. S., Ye, C., Kumar, P., Chiu, I., Subramanya, S., Wu, H., Shankar, P., and Manjunath, N. (2010) Targeted delivery of siRNA to macrophages for anti-inflammatory treatment Mol. Ther. 18, 993-1001
129. Subramanya, S., Kim, S. S., Abraham, S., Yao, J., Kumar, M., Kumar, P., Haridas, V., Lee, S. K., Shultz, L. D., Greiner, D., N, M., and Shankar, P. (2010) Targeted delivery of small interfering RNA to human dendritic cells to suppress dengue virus infection and associated proinflammatory cytokine production J. Virol. 84, 2490-501
130. Song, E., Zhu, P., Lee, S. K., Chowdhury, D., Kussman, S., Dykxhoorn, D. M., Feng, Y., Palliser, D., Weiner, D. B., Shankar, P., Marasco, W. A., and Lieberman, J. (2005) Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors Nat. Biotechnol. 23, 709-17 (Pubitemid 41716361)
131. Peer, D., Zhu, P., Carman, C. V., Lieberman, J., and Shimaoka, M. (2007) Selective gene silencing in activated leukocytes by targeting siRNAs to the integrin lymphocyte function-associated antigen-1 Proc. Natl. Acad. Sci. U. S. A. 104, 4095-100 (Pubitemid 47181584)
132. Rozema, D. B., Lewis, D. L., Wakefield, D. H., Wong, S. C., Klein, J. J., Roesch, P. L., Bertin, S. L., Reppen, T. W., Chu, Q., Blokhin, A. V., Hagstrom, J. E., and Wolff, J. A. (2007) Dynamic PolyConjugates for targeted in vivo delivery of siRNA to hepatocytes Proc. Natl. Acad. Sci. U. S. A. 104, 12982-7 (Pubitemid 351737577)
133. Oishi, M., Nagasaki, Y., Nishiyama, N., Itaka, K., Takagi, M., Shimamoto, A., Furuichi, Y., and Kataoka, K. (2007) Enhanced growth inhibition of hepatic multicellular tumor spheroids by lactosylated poly(ethylene glycol)-siRNA conjugate formulated in PEGylated polyplexes ChemMedChem 2, 1290-7
134. Chen, Y., Bathula, S. R., Yang, Q., and Huang, L. (2010) Targeted nanoparticles deliver siRNA to melanoma J. Invest. Dermatol. 130, 2790-8
135. Li, J., Chen, Y. C., Tseng, Y. C., Mozumdar, S., and Huang, L. (2010) Biodegradable calcium phosphate nanoparticle with lipid coating for systemic siRNA delivery J. Controlled Release 142, 416-21
136. Davis, M. E., Zuckerman, J. E., Choi, C. H., Seligson, D., Tolcher, A., Alabi, C. A., Yen, Y., Heidel, J. D., and Ribas, A. (2010) Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles Nature 464, 1067-70
137. Bartlett, D. W. and Davis, M. E. (2007) Physicochemical and biological characterization of targeted, nucleic acid-containing nanoparticles Bioconjugate Chem. 18, 456-68 (Pubitemid 46493517)
138. Bartlett, D. W., Su, H., Hildebrandt, I. J., Weber, W. A., and Davis, M. E. (2007) Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging Proc. Natl. Acad. Sci. U. S. A. 104, 15549-54 (Pubitemid 47502954)